Tempest Therapeutics, Inc. — Form 8-K
Filed October 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Form 8-K filed 2026-10-20 reports submission of matters to a vote of security holders (Item 5.07) and other events (Item 8.01) with period of report 2026-10-14. The specific proposals voted on, voting results, and details of other events are not disclosed in the provided filing header and document listing—only structural metadata (XBRL files, company address, CIK) are present.
Why this rating
No substantive business information disclosed; routine stockholder vote reporting without outcome detail or material event specifics.
Extracted items
- 5.07 shareholder vote
- 8.01 other event
See more from October 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.